Avik Shome

Auckland, AUK 1142, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to "Desacetyl-alpha-melanocyte stimulating hormone and alpha-melanocyte stimulating hormone are required to regulate energy balance" [Mol Metab 9 (2018) 207-216/29226825].

Corrigendum to "Desacetyl-alpha-melanocyte stimulating hormone and alpha-melanocyte stimulating hormone are required to regulate energy balance" [Mol Metab 9 (2018) 207-216/29226825].

Journal: Molecular metabolism

Published: May 07, 2026

Quantitative imaging for assessing uveitis activity: A comprehensive review.

Quantitative imaging for assessing uveitis activity: A comprehensive review.

Journal: Survey of ophthalmology

Published: December 31, 2025

A Cationic Block Co-Polymer for Gene Delivery in the Posterior Segment of the Eye.

A Cationic Block Co-Polymer for Gene Delivery in the Posterior Segment of the Eye.

Journal: Journal of biomedical materials research. Part A

Published: September 16, 2025

Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis.

Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis.

Journal: European journal of pharmacology

Published: August 28, 2025

The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis.

The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis.

Journal: Animal models and experimental medicine

Published: October 30, 2024

Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers.

Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers.

Journal: Journal of medicinal chemistry

Published: July 15, 2024

Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice.

Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice.

Journal: Biomedicines

Published: May 22, 2023

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.

Journal: Molecules (Basel, Switzerland)

Published: May 05, 2023

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma.

Journal: JCI insight

Published: February 22, 2023

Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.

Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: January 13, 2023

Blocking the inflammasome: A novel approach to treat uveitis.

Blocking the inflammasome: A novel approach to treat uveitis.

Journal: Drug discovery today

Published: January 25, 2021

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.

Journal: International journal of molecular sciences

Published: November 11, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026